We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Delta Gold Technologies PLC (AQSE:DGQ) has completed a £1,922,500 capital raise through a direct subscription, issuing 5,492,853 new ordinary shares priced at 35p each, the company said Tuesday.
The newly issued shares account for approximately 8.51% of the group’s enlarged share capital. Investors participating in the subscription will receive one warrant for every two shares purchased, resulting in 2,746,425 warrants in total. Each warrant carries an exercise price of 50p per ordinary share.
The warrants are subject to an acceleration provision, which would be triggered if the company’s volume-weighted average share price exceeds 70p over any 10 consecutive trading days. They will lapse two years after the subscription shares are admitted to trading on the Aquis exchange.
The company confirmed that Purebond Ltd has joined the shareholder register as part of the fundraising. Proceeds will be directed toward expanding and accelerating university-based research partnerships and collaborations, alongside supporting general working capital needs.
“We are delighted by the strong support from new and existing shareholders,” said R. Michael Jones, Chief Executive Officer of Delta, according to the company’s press release. He added that Delta is broadening its academic network beyond its existing relationship with the University of Toronto to include Penn State University.
Admission of the new shares to trading on Aquis is anticipated on or around February 20, 2026. Upon completion, Delta’s total issued share capital is expected to consist of 64,501,507 ordinary shares with a nominal value of 0.2p each.
More about Delta Gold Technologies
Delta Gold Technologies is focused on building and commercializing intellectual property within the quantum computing field, with a particular concentration on nano-scale gold and advanced material applications.
This article was written by the editorial team at InvestorsHub/ADVFN and is provided for informational purposes only. In some cases, editorial staff may use artificial intelligence–based tools to assist in the research, drafting, or editing of content, under human review and oversight. This article does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. The views expressed are based on publicly available information believed to be reliable at the time of publication, but accuracy or completeness is not guaranteed. Readers should conduct their own independent research and consult a qualified financial professional before making any investment decisions.
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions